Skip to content

IV Acetaminophen and Post-Tonsillectomy Pain

Randomized Prospective Study Investigating the Analgesic Efficacy of Intravenous Acetaminophen in Reducing Post-Tonsillectomy Pain in Pediatric Patients

Status
Withdrawn
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03883893
Enrollment
0
Registered
2019-03-21
Start date
2021-12-31
Completion date
2023-04-30
Last updated
2022-04-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tonsillectomy, Adenoidectomy

Keywords

Tonsillectomy, Intravenous Acetaminophen, Pediatric

Brief summary

This study is a randomized prospective study to compare the post-operative analgesic efficacy of intravenous acetaminophen 15 mg/kg to an equal volume of 0.9% normal saline when all other analgesic interventions have been standardized for all patients enrolled.

Interventions

Intravenous acetaminophen will be given in the OR.

OTHERNormal saline

Normal saline will given if randomized to this group.

Sponsors

Children's Hospital Medical Center, Cincinnati
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Investigator)

Masking description

Clinical research coordinator, parent and participant will be masked until participant is discharged from hospital. OR staff will not be masked.

Eligibility

Sex/Gender
ALL
Age
3 Years to 10 Years
Healthy volunteers
No

Inclusion criteria

1. The subject is age 3 to 10 years (inclusive) 2. The subject weighs more than 10.0 kg (inclusive of the tenth kilogram) 3. The subject is scheduled for the following: Elective tonsillectomy or tonsillectomy with adenoidectomy scheduled on an outpatient basis, with acceptable inclusion of patients also having PETs and/or EUA of ear 4. The subject is ASA patient classification I-II 5. The subject's legally authorized representative has given written informed consent to participate in the study and when appropriate, the subject has given assent or consent to participate.

Exclusion criteria

1. Additional surgical procedures are being performed concurrently; 2. The subject is ASA classification \> II; 3. The subject has pre-existing allergy or known hypersensitivity to acetaminophen; 4. The subject receives midazolam as a premedication; 5. The subject has a history of chronic malnutrition; 6. The subject has any other condition, which in the opinion of the principal investigator, would not be suitable for participation in the study

Design outcomes

Primary

MeasureTime frameDescription
Post-operative pain scoresEvery 5 minutes after awake in recovery room for 30 minutesFLACC (Face, Legs, Activity, Cry, Consolability) behavior scale Each area measured is graded 0 - 2 and then totaled. Total score will range from 0 - 10. A total score of 0 - patient is relaxed and comfortable, 1 - 3 - patient is mildly uncomfortable, 4 - 6 - patient is in moderate pain, 7 - 10 - patient is having severe discomfort/pain

Secondary

MeasureTime frameDescription
Quality of emergence from anesthesiaWhen first spontaneous eye movement occurs in recovery roomPediatric Anesthesia Emergence Delirium scale (PAED) This scale uses 5 criteria to determine the extent of emergence delirium in children. The child makes eye contact with the caregiver, The child's actions are purposeful, The child is aware of his/her surroundings, The child is restless and The child is inconsolable. Each of these 5 catagories are scored on a 0-4 scale. The higher the total number the greater the extent of the emergence delirium.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026